• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 99-113 of 313 results

1018 Exhibit: Declaration of Elaine S Gilmore, MD, PhD

Document IPR2019-01095, No. 1018-17 Exhibit - Declaration of Elaine S Gilmore, MD, PhD (P.T.A.B. Jun. 7, 2019)
Inter Partes Review of U.S. Patent No. 9,517,219 Declaration of Elaine S. Gilmore, M.D., Ph.D. (Exhibit 1018) claimed invention; the analysis may include recourse to logic, judgment, and common sense available to a person of ordinary skill that does not necessarily require an explicit teaching, suggestion, or motivation in any reference.
without a certification in dermatology (i.e., a primary care physician, or a pediatrician) may qualify as a clinical POSA, assuming that they have more than two years of knowledge and experience treating skin conditions.
Inter Partes Review of U.S. Patent No. 9,517,219 Declaration of Elaine S. Gilmore, M.D., Ph.D. (Exhibit 1018) mg/week.” (Id., 1:8-11; see also AMN1007, [0003] [explaining that dapsone can be used to treat acne, rosacea, and other “skin diseases characterized by the abnormal infiltration of neutrophils.”].)
(AMN1004, 1) A POSA in 2012 would understand that Garrett teaches methods of treating both rosacea and acne consisting of inflammatory and non-inflammatory lesions by applying topical compositions containing dapsone to a patient’s affected areas.
First, the reduction in number of daily applications is not unexpected, as dermatologists expected at the time of invention that the potency, or strength, of a given drug is related to both its duration of action and its side effects.
cite Cite Document
Analyze

1038 Exhibit: Curriculum Vitae for Marc Serota, MD

Document IPR2019-01095, No. 1038-34 Exhibit - Curriculum Vitae for Marc Serota, MD (P.T.A.B. Jun. 7, 2019)
Log in to see more
cite Cite Document
Analyze

1034 Exhibit: Andersson, D, Evonik Degussa expands itscooperation with Alsiano, Pharma Healthcare News 1 102007

Document IPR2019-01095, No. 1034-30 Exhibit - Andersson, D, Evonik Degussa expands itscooperation with Alsiano, Pharma Healthcare News 1 102007 (P.T.A.B. Jun. 7, 2019)
Log in to see more
cite Cite Document
Analyze

1008 Exhibit: US Patent Publication No 20100029781 Morris

Document IPR2019-01095, No. 1008-8 Exhibit - US Patent Publication No 20100029781 Morris (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze

1010 Exhibit: Physicians Desk Reference, 65th ed, pp 599 602 2011ACZONE Gel 5...

Document IPR2019-01095, No. 1010-10 Exhibit - Physicians Desk Reference, 65th ed, pp 599 602 2011ACZONE Gel 5% Label (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze

1015 Exhibit: Bonacucina, G, et al, Characterization and Stability of Emulsion Gels Based on AcrylamideSodium Acryloyldimethyl Taurate Copolymer, AAPS PharmaSciTech 10368 375 2009 Bonacucina

Document IPR2019-01095, No. 1015-15 Exhibit - Bonacucina, G, et al, Characterization and Stability of Emulsion Gels Based on AcrylamideSodium Acryloyldimethyl Taurate Copolymer, AAPS PharmaSci...
Log in to see more
cite Cite Document
Analyze

1031 Exhibit: Spains Almirall bets on dermatology with $650 million US deal, Retrie...

Document IPR2019-01095, No. 1031-28 Exhibit - Spains Almirall bets on dermatology with $650 million US deal, Retrieved from httpswwwreuterscomarticleus allergan m a almirallspains almirall bets on de...

cite Cite Document
Analyze

1024 Exhibit: Nguyen, R and Su, J, Treatment of Acne Vulgaris Pediatrics and Child...

Document IPR2019-01095, No. 1024-22 Exhibit - Nguyen, R and Su, J, Treatment of Acne Vulgaris Pediatrics and Child Health 21 119 125 2010 Nguyen (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze

2001 Exhibit: Exhibit 2001 Declaration of Elizabeth B Hagan in Support of Patent O...

Document IPR2019-01095, No. 2001-36 Exhibit - Exhibit 2001 Declaration of Elizabeth B Hagan in Support of Patent Owner Almirall, LLCs Motion for Admission Pro Hac Vice (P.T.A.B. Jul. 2, 2019)

cite Cite Document
Analyze

1023 Exhibit: Thiboutot, D, et al, Pharmacokinetics of Dapsone Gel, 5% for the Trea...

Document IPR2019-01095, No. 1023-21 Exhibit - Thiboutot, D, et al, Pharmacokinetics of Dapsone Gel, 5% for the Treatment of Acne Vulgaris Clin Pharmacokinet 46 697 712 2007 Thiboutot (P.T.A.B. Jun...

cite Cite Document
Analyze

1027 Exhibit: Barclay, L, Use of Topical Corticosteroids for Dermatologic Conditions...

Document IPR2019-01095, No. 1027-25 Exhibit - Barclay, L, Use of Topical Corticosteroids for Dermatologic Conditions Reviewed Medscape Jan 21, 2009, accessed from httpswwwmedscapecomviewarti...

cite Cite Document
Analyze

1025 Exhibit: Williams, H, et al, Acne vulgaris Lancet 379 361 72 2012 Williams

Document IPR2019-01095, No. 1025-23 Exhibit - Williams, H, et al, Acne vulgaris Lancet 379 361 72 2012 Williams (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze

1037 Exhibit: Declaration of Marc Serota, MD

Document IPR2019-01095, No. 1037-33 Exhibit - Declaration of Marc Serota, MD (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze

1002 Exhibit: Declaration of Bozena B Michniak Kohn, PhD, FAAPS, MRPharmS

Document IPR2019-01095, No. 1002-2 Exhibit - Declaration of Bozena B Michniak Kohn, PhD, FAAPS, MRPharmS (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze

1019 Exhibit: Curriculum Vitae for Elaine S Gilmore, MD, PhD

Document IPR2019-01095, No. 1019-18 Exhibit - Curriculum Vitae for Elaine S Gilmore, MD, PhD (P.T.A.B. Jun. 7, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 11 ... >>